The Report read as follows:
Your Subcommittee met on Tuesday, March 23, 2010, to consider the business of the Committee and agreed to make the following recommendations:
1. That on Tuesday, April 13, 2010, and on Thursday, April 15, 2010, the Committee review the government's decision to cancel its commitment to create an HIV vaccine manufacturing facility through the Canadian HIV Vaccine Initiative and explore the possible link between the International Centre for Infectious Diseases (ICID) and the level 5 laboratory, that it call witnesses in this regard, and issue a report of its findings to the House;
2. That on Tuesday, April 20, 2010, the Committee study the elevated rates of tuberculosis infection in First Nations and Inuit communities and report its conclusions, including recommendations toward a national strategy to eradicate this disease, to the House of Commons;
3. That the Committee meetings of Thursday, April 22, 2010, and of Thursday, May 13, 2010, be devoted to the study of Health Human Resources (HHR), and that on Tuesday, May 25, 2010, the Committee meeting be devoted to the consideration of the Health Human Resources (HHR) draft report;
4. That on Tuesday, April 27, 2010, and on Thursday, April 29, 2010, the Committee study the impact of microwaves on human health;
5. That on Tuesday, May 4, 2010, the Committee meeting be devoted to the study on Sodium Consumption in the Canadian Diet;
6. That on Thursday, May 6, 2010, the Committee study Health Canada's Trans Fat Monitoring Program;
7. That on Tuesday, May 11, 2010, and on Thursday, May 27, 2010, the Committee study the topic of nanotechnology;
8. That on Tuesday, June 1, 2010, the Committee study the topic of caffeine;
9. That on Thursday, June 3, 2010, and on Tuesday, June 8, 2010, the Committee study the listeriosis investigative review and determine the status of each of the 57 recommendations made in the Weatherill Report as they pertain to the Health Committee mandate;
10. That on Thursday, June 10, 2010, the Committee meeting be devoted to identify lessons learned from the H1N1 response, including: collaboration with the provinces and territories, manufacturing of the vaccine and distribution to Canadians; and make recommendations to address needs, including: disease surveillance, hospital surge capacity, public health workforce and vaccine production capacity and to study the spring wave of H1N1 in Aboriginal communities, including: the spread of the virus, pandemic preparedness, social-environmental conditions, and underlying health conditions in H1N1-affected communities, treatment and health impacts and, federal, provincial and territorial responses.